JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: OVERSEAS REGULATORY ANNOUNCEMENT
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL NEW DRUG APPLICATIONFOR TORIPALIMAB AS THE FIRST-LINE TREATMENTOF MELANOMA
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: INSIDE INFORMATION -RECEIPT OF A POSITIVE OPINION FROM THE COMMITTEE FORMEDICINAL PRODUCTS FOR HUMAN USE OFTHE EUROPEAN MEDICINES AGENCY FOR TORIPALIMAB
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL NEW DRUG APPLICATION FOR TORIPALIMAB IN COMBINATION WITH BEVACIZUMAB FOR THE FIRST-LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - WHOLLY-OWNED SUBSIDIARY OBTAINING THE EU GMP CERTIFICATE
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - JS125 RECEIVED THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
No Data